HEALTH AND HUMAN SERVICES, DEPARTMENT OF › CENTERS FOR DISEASE CONTROL AND PREVENTION › CDC OFFICE OF ACQUISITION SERVICES
Serological Assays for the Detection and Characterization of Influenza Viruses
Key facts
- Response deadline
- Feb 15, 2026
- 2:00 PM UTC-05:00
- Set-aside
- Not stated
- Notice type
- Solicitation
- Posted on SAM.gov
- Dec 11, 2025
- Archives Dec 15, 2026
Description
Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.
From SAM.gov’s daily data file, as published on Oct 24, 2026 (UTC).
Contacts
Jennifer Gartzke · primary
Attachments
BidLookup records the links this notice gives. It has not downloaded or checked the files.
Record dates
- Posted on SAM.gov: Dec 11, 2025
- The agency’s publication date, as SAM.gov states it.
- First recorded by BidLookup: Oct 8, 2026
- The UTC day of the first read of SAM.gov’s listings that stored this notice.
- Last confirmed: Oct 23, 2026
- The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
- Description as published: Oct 24, 2026 (UTC)
- The date of the daily data file this text came from.
Published by the agency on SAM.gov as notice f2c10f433ad1479e9f5f46649b15915c. What these dates mean
Record
- Solicitation number
- 75D30125R73235
- Search the index for this number
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product/service code
- Q301 · REFERENCE LABORATORY TESTING
- Place of performance
- Atlanta, Georgia
- Contracting office
- ATLANTA, GA 30333
- SAM.gov notice ID
- f2c10f433ad1479e9f5f46649b15915c